Sustained Therapeutics is developing a sustained-release drug delivery platform using a soft polymer gel to provide targeted, non-opioid pain relief through local injection. This technology aims to address the limitations of current pain management treatments by offering prolonged relief with fewer side effects for conditions such as post-surgical pain and cancer.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current pain management treatments, such as opioids and anti-inflammatories, often provide only short-term relief and can be expensive, highly addictive, and associated with significant side effects. A large portion of the population suffers from chronic pain, highlighting the need for more effective and safer alternatives.
Solution
Sustained Therapeutics is developing a patented drug delivery platform based on a soft polymer gel designed for local injection to provide targeted, non-opioid pain relief. The gel is engineered to release medication slowly and in a highly controlled manner, potentially offering prolonged relief over days, weeks, or even months. This sustained-release approach aims to reduce the need for frequent dosing and minimize systemic side effects, improving the management of both acute and chronic pain conditions. Clinical trials are underway to evaluate the feasibility and efficacy of this technology.
Target Audience
The primary target audience includes patients suffering from acute or chronic pain, as well as healthcare providers seeking safer and more effective pain management solutions.
Features
- Soft polymer gel for targeted drug delivery via local injection.
- Sustained-release mechanism for prolonged pain relief.
- Non-opioid approach to minimize the risk of addiction and related side effects.
- Controlled drug release to maintain therapeutic levels over extended periods.
- Potential application for various acute and chronic conditions, including post-surgical pain, fibrotic and inflammatory diseases, and cancer.